Inflammatory levels of interleukin 1 alpha are present in the majority of open comedones in acne vulgaris
Eady, E.A.; Goodwin, C.E.; Cove, J.H.; Ingham, E.; Cunliffe, W.J.
Archives of Dermatology 127(8): 1238-1239
1991
ISSN/ISBN: 0003-987X PMID: 1830734 Document Number: 387742
Document emailed within 1 workday
Related Documents
Resh, W.; Stoughton, R.B. 1976: Topically applied antibiotics in acne vulgaris: clinical response and suppression of Corynebacterium acnes in open comedones Archives of Dermatology 112(2): 182-184Tanghetti, E.; Dhawan, S.; Green, L.; Ling, M.; Downie, J.; Germain, M.A.; Kasteler, J.S.; Kircik, L.; Oefelein, M.G.; Draelos, Z. 2011: Clinical evidence for the role of a topical anti-inflammatory agent in comedonal acne: findings from a randomized study of dapsone gel 5% in combination with tazarotene cream 0.1% in patients with acne vulgaris Journal of Drugs in Dermatology: Jdd 10(7): 783-792
Alecu, M.; Geleriu, L.; Coman, G.; Gălăţescu, L. 1998: The interleukin-1, interleukin-2, interleukin-6 and tumour necrosis factor alpha serological levels in localised and systemic sclerosis Romanian Journal of Internal Medicine 36(3-4): 251-259
Onumah, N. 2013: A novel anti-inflammatory in treatment of acne vulgaris: the pseudopterosins Journal of Drugs in Dermatology: Jdd 12(10): 1177-1179
Thiboutot, D. 2008: Versatility of azelaic acid 15% gel in treatment of inflammatory acne vulgaris Journal of Drugs in Dermatology: Jdd 7(1): 13-16
Del Rosso, J.Q.; Schmidt, N.F. 2010: A review of the anti-inflammatory properties of clindamycin in the treatment of acne vulgaris Cutis 85(1): 15-24
Wokalek, H. 1989: Open, controlled multicenter trial of 2 benzoyl peroxide preparations in the treatment of acne vulgaris Zeitschrift für Hautkrankheiten 64(2): 140-144
Leyden, J.J.; Bruce, S.; Lee, C.S.; Ling, M.; Sheth, P.B.; Stewart, D.M.; Werschler, W.P.; Gilbert, R.D.; Kircik, L. 2013: A randomized, phase 2, dose-ranging study in the treatment of moderate to severe inflammatory facial acne vulgaris with doxycycline calcium Journal of Drugs in Dermatology: Jdd 12(6): 658-663
Shi, B.; Nakazawa, H.; Ryoji, O.; Goya, N.; Ito, F.; Koga, S.; Okuda, H.; Kobayashi, H.; Toma, H. 1998: Study on urinary levels of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha in patients with renal cell carcinoma Hinyokika Kiyo. Acta Urologica Japonica 44(3): 143-147
Gold, M.H.; Biron, J.A.; Boring, M.; Bridges, T.M.; Bradshaw, V.L. 2007: Treatment of moderate to severe inflammatory acne vulgaris: photodynamic therapy with 5-aminolevulinic acid and a novel advanced fluorescence technology pulsed light source Journal of Drugs in Dermatology: Jdd 6(3): 319-322
Gold, M.H.; Rao, J.; Goldman, M.P.; Bridges, T.M.; Bradshaw, V.L.; Boring, M.M.; Guider, A.N. 2005: A multicenter clinical evaluation of the treatment of mild to moderate inflammatory acne vulgaris of the face with visible blue light in comparison to topical 1% clindamycin antibiotic solution Journal of Drugs in Dermatology: Jdd 4(1): 64-70
Kamal, M.; Polat, M. 2015: Effect of different doses of isotretinoin treatment on the levels of serum homocysteine, vitamin B 12 and folic acid in patients with acne vulgaris: a prospective controlled study JPMA. Journal of the Pakistan Medical Association 65(9): 950-953
Ghorpade, A.; Reddy, B.S.N.; Rizvi, S.N.A. 1982: Plasma Zinc Levels and the Effect of Oral Zinc in Acne Vulgaris Indian Journal of Dermatology Venereology and Leprology 48(3): 129-137
Mazurkiewicz, W.; Kostanecki, W.; Blaszczyk, M.; Dabrowska, H. 1974: Treatment of some diseases involving keratinization such as acne vulgaris and acne phlegmonosa with vitamin a acid Przeglad Dermatologiczny 61(1): 61-64
Zaenglein, A.L.; Shamban, A.; Webster, G.; Del Rosso, J.; Dover, J.S.; Swinyer, L.; Stein, L.; Lin, X.; Draelos, Z.; Gold, M.; Thiboutot, D. 2013: A phase IV, open-label study evaluating the use of triple-combination therapy with minocycline HCl extended-release tablets, a topical antibiotic/retinoid preparation and benzoyl peroxide in patients with moderate to severe acne vulgaris Journal of Drugs in Dermatology: Jdd 12(6): 619-625
Sakai, H.; Mori, K.; Suzuki, K.; Katayama, Y.; Matsuyama, T. 1994: The clinical significance of interleukin-6 as an inflammatory marker (the studies in patients with open heart surgery) Rinsho Byori. Japanese Journal of Clinical Pathology 42(11): 1151-1157
Kircik, L.H.; Dahl, A.; Yatskayer, M.; Raab, S.; Oresajo, C. 2012: Safety and efficacy of two anti-acne/anti-aging treatments in subjects with photodamaged skin and mild to moderate acne vulgaris Journal of Drugs in Dermatology: Jdd 11(6): 737-740
Castelli, C.; Sensi, M.; Lupetti, R.; Mortarini, R.; Panceri, P.; Anichini, A.; Parmiani, G. 1994: Expression of interleukin 1 alpha, interleukin 6, and tumor necrosis factor alpha genes in human melanoma clones is associated with that of mutated N-RAS oncogene Cancer Research 54(17): 4785-4790
Valcamonica, E.; Chighizola, C.B.; Comi, D.; De Lucia, O.; Pisoni, L.; Murgo, A.; Salvi, V.; Sozzani, S.; Meroni, P.L. 2014: Levels of chemerin and interleukin 8 in the synovial fluid of patients with inflammatory arthritides and osteoarthritis Clinical and Experimental Rheumatology 32(2): 243-250
Barillé, S.; Bataille, R.; Amiot, M. 2000: The role of interleukin-6 and interleukin-6/interleukin-6 receptor-alpha complex in the pathogenesis of multiple myeloma European Cytokine Network 11(4): 546-551